Artiva Biotherapeutics, Inc.
ARTV
$11.78
$0.564.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 86.78M | 108.01M | 122.97M | 142.37M | 165.96M |
| Total Receivables | 600.00K | 767.00K | 879.00K | 1.03M | 234.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.36M | 3.89M | 5.68M | 5.67M | 3.81M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 88.74M | 112.67M | 129.52M | 149.07M | 170.00M |
|
|
|||||
| Total Current Assets | 88.74M | 112.67M | 129.52M | 149.07M | 170.00M |
| Net Property, Plant & Equipment | 16.30M | 17.36M | 18.46M | 19.83M | 20.79M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 919.00K | 919.00K | 879.00K | 499.00K | 474.00K |
| Total Assets | 105.96M | 130.94M | 148.86M | 169.39M | 191.26M |
|
|
|||||
| Total Accounts Payable | 2.29M | 355.00K | 848.00K | 1.22M | 2.04M |
| Total Accrued Expenses | 5.56M | 9.60M | 7.03M | 5.84M | 6.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.04M | 3.06M | 3.17M | 3.64M | 3.72M |
| Total Finance Division Other Current Liabilities | -- | 73.00K | 73.00K | 73.00K | 73.00K |
| Total Other Current Liabilities | -- | 73.00K | 73.00K | 73.00K | 73.00K |
| Total Current Liabilities | 10.88M | 13.09M | 11.12M | 10.77M | 12.20M |
|
|
|||||
| Total Current Liabilities | 10.88M | 13.09M | 11.12M | 10.77M | 12.20M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.23M | 7.88M | 8.52M | 9.58M | 10.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.11M | 20.97M | 19.64M | 20.35M | 22.48M |
|
|
|||||
| Common Stock & APIC | 441.93M | 440.42M | 438.91M | 437.29M | 435.78M |
| Retained Earnings | -354.07M | -330.55M | -309.78M | -288.25M | -267.00M |
| Treasury Stock & Other | -18.00K | 103.00K | 87.00K | 2.00K | -- |
| Total Common Equity | 87.85M | 109.97M | 129.22M | 149.04M | 168.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 87.85M | 109.97M | 129.22M | 149.04M | 168.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 87.85M | 109.97M | 129.22M | 149.04M | 168.78M |
|
|
|||||